615
Participants
Start Date
November 30, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
AZD9668
2 x 30 mg oral tablets bd for 12 weeks
Placebo
2 x matched placebo to oral tablet bd for 12 weeks
Research Site, Lovech
Research Site, Pleven
Research Site, Plovdiv
Research Site, Rousse
Research Site, Sofia
Research Site, Stara Zagora
Research Site, Troyan Municipality
Research Site, Varna
Research Site, Jihlava
Research Site, Jindřichův Hradec
Research Site, Kladno
Research Site, Krnov
Research Site, Nový Jičín
Research Site, Pardubice
Research Site, Prague
Research Site, Rokycany
Research Site, Třebíč
Research Site, Balassagyarmat
Research Site, Budapest
Research Site, Debrecen
Research Site, Deszk
Research Site, Győr
Research Site, Nyíregyháza
Research Site, Pécs
Research Site, Százhalombatta
Research Site, Szombathely
Research Site, Törökbálint
Research Site, Vásárosnamény
Research Site, Bialystok
Research Site, Gdynia
Research Site, Gorzow Wlkp
Research Site, Grodzisk Mazowiecki
Research Site, Jelenia Góra
Research Site, Katowice
Research Site, Kielce
Research Site, Krakow
Research Site, Lodz
Research Site, Lublin
Research Site, Piła
Research Site, Skierniewice
Research Site, Szczecin
Research Site, Tarnów
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Constanța
Research Site, Deva
Research Site, Bucharest
Research Site, Bucharest
Research Site, Iași
Research Site, Bardejov
Research Site, Bojnice
Research Site, Bratislava
Research Site, Dunajská Streda
Research Site, Humenné
Research Site, Košice
Research Site, Liptovský Hrádok
Research Site, Nové Mesto nad Váhom
Research Site, Nové Zámky
Research Site, Poprad
Research Site, Považská Bystrica
Research Site, Prešov
Research Site, Revúca
Research Site, Spišská Nová Ves
Research Site, Trnava
Research Site, Trstená
Research Site, Žilina
Lead Sponsor
AstraZeneca
INDUSTRY